Clinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular Disease
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index; 34 of the 66 sources its claims cite were checked for support.
Abstract
BACKGROUND: Type 2 diabetes and cardiovascular disease impose substantial clinical and economic burdens for seniors (age 65 and above) and the Medicare program. Intensive Behavioral Counseling (IBC) interventions like the National Diabetes Prevention Program (NDPP), have demonstrated effectiveness in reducing excess body weight and lowering or delaying morbidity onset. This paper estimated the potential health implications and medical savings of a digital version of IBC modeled after the NDPP. METHODS AND FINDINGS: Participants in this digital IBC intervention, the Omada program, include 1,121 overweight or obese seniors with additional risk factors for diabetes or heart disease. Weight changes were objectively measured via participant use of a networked weight scale. Participants averaged 6.8% reduction in body weight within 26 weeks, and 89% of participants completed 9 or more of the 16 core phase lessons. We used a Markov-based microsimulation model to simulate the impact of weight loss on future health states and medical expenditures over 10 years. Cumulative per capita medical expenditure savings over 3, 5 and 10 years ranged from $1,720 to 1,770 (3 years), $3,840 to $4,240 (5 years) and $11,550 to $14,200 (10 years). The range reflects assumptions of weight re-gain similar to that seen in the DPP clinical trial (lower bound) or minimal weight re-gain aligned with age-adjusted national averages (upper bound). The estimated net economic benefit after IBC costs is $10,250 to $12,840 cumulative over 10 years. Simulation outcomes suggest reduced incidence of diabetes by 27-41% for participants with prediabetes, and stroke by approximately 15% over 5 years. CONCLUSIONS: A digital, remotely-delivered IBC program can help seniors at risk for diabetes and cardiovascular disease achieve significant weight loss, reduces risk for diabetes and cardiovascular disease, and achieve meaningful medical cost savings. These findings affirm recommendations for IBC coverage by the U.S. Preventive Services Task Force.
Overview
CoChat Summary
TL;DR
In 1,121 Medicare-age seniors with prediabetes or cardiovascular risk factors, a digital remotely delivered intensive behavioral counseling program produced 6.8% average weight loss at 26 weeks (7.3% among completers), with 89.5% completing ≥9 core lessons. A 10-year Markov microsimulation estimated per capita medical savings of $11,550–$14,200 and net savings after program costs of $10,250–$12,840 for the CVD-risk population, alongside reduced modeled diabetes and stroke incidence.
Key findings
- Weight loss: intent-to-treat participants averaged 6.8% body weight reduction within 26 weeks; program completers averaged 7.3%; 89.5% completed 9 or more core lessons.
- Modeled disease reduction: among participants with prediabetes, diabetes onset was 26.6–41.1% lower at 5 years; among the CVD-risk population, stroke incidence was 14.5–15.1% lower over 5 years.
- Per capita medical expenditure savings for the CVD-risk population were $1,720–$1,770 at 3 years, $3,840–$4,240 at 5 years, and $11,550–$14,200 at 10 years; net 10-year savings after IBC costs were $10,250–$12,840.
- For the prediabetes population, 10-year per capita savings were $12,010–$16,390, with net 10-year savings of $10,710–$13,240.
Methods
- Analyzed 1,121 adults age 65 and over enrolled in the Omada digital IBC program between 2012 and 2015 for at least 16 weeks with baseline BMI ≥24 kg/m²; 997 (88.9%) had prediabetes; completers were defined as participants completing ≥9 lessons (N = 1,003). Weight change was measured via a networked scale from baseline to the last recorded weight between weeks 17 and 26.
- Missing clinical variables were filled by 1:1 propensity-score matching to NHANES 2005–2012 records based on age, sex, race/ethnicity, starting BMI, prediabetes status, and presence of CVD risk factors.
- Used a Markov-based microsimulation model over 10 years with annual cycles under control, partial weight regain, and sustained weight loss scenarios; medical expenditures were modeled from 2009–2013 MEPS data in 2015 dollars with a 3% discount rate, and intervention cost was estimated at $1,300 over 3 years.
Limitations
- Stated: Participants voluntarily enrolled in a digital program and may not reflect the general Medicare beneficiary population; weight loss was the only clinical data collected from participants, with other baseline clinical values created through NHANES propensity matching.
- Stated: Medical expenditure equations reflect total expenditures, including Medicare payments, patient out-of-pocket expenses, and supplementary insurance, so the exact Medicare share is unclear; the model also uses some older and non-US data sources.
- Evident from the text: This is a single-arm observational analysis without a randomized control group, and clinical/economic outcomes beyond weight loss come from a microsimulation under assumptions about weight regain rather than directly observed events.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
14 Valid · 4 Not valid · 11 Not checked · 61 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Furthermore, the 10- and 15-year follow-up studies continued to show reduced incidence of diabetes by 34% and 27%, respectively, relative to the control group [1,2].”
§ Clinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular Disease > Introduction
What the sources say
- Supportedcites [1] 2015, Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study, Lancet Diabetes Endocrinol source
The Results section (“Incidence of Diabetes”; page not provided) reports that diabetes incidence after an average 15-year follow-up was 27% lower with lifestyle intervention than with placebo. This supports the 15-year figure attributed to this paper; the sentence also cites a separate source for the 10-year figure. (LLM, conf=0.92)
- Partly supportedcites [2] WC Knowler, 2009, 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study, Lancet sourceExperimental — accuracy not yet measured
The Results (page not provided) report a 34% lower diabetes incidence rate in the lifestyle group than in the placebo group over the combined DPP and DPPOS periods, covering about 10 years. This paper does not report the claimed 15-year follow-up or its 27% reduction. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A digital, remotely-delivered IBC program that is an enhanced version of the original NDPP demonstrated clinical efficacy [13–16].”
§ Clinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular Disease > Introduction
What the sources say
- Supportedcites [13] SC Sepah, 2015, Long-term outcomes of a Web-based diabetes prevention program: 2-year results of a single-arm longitudinal study, J Med Internet Res source
The Methods > Program section describes Prevent as an Internet-based translation of the Diabetes Prevention Program with online group support, health coaching, and digital tracking. The Discussion > Principal Findings reports significant reductions in body weight and A1c after two years, supporting the claim of clinical benefit. The study was single-arm, so it does not establish efficacy relative to a control group. (LLM, conf=0.88)
- Supportedcites [14] W Su, 2016, Return on Investment for Digital Behavioral Counseling in Patients With Prediabetes and Cardiovascular Disease, Prev Chronic Dis source
The Introduction describes Prevent as a digital counseling program that enhances the CDC’s Diabetes Prevention Recognition Program and uses online tools and support. The Methods report weight loss and improved HbA1c in a published pilot study, and the Discussion says previous work found Prevent effective among people with prediabetes. This paper reports that evidence rather than presenting its return-on-investment simulation as a clinical efficacy trial. (LLM, conf=0.88)
- Supportedcites [15] SC Sepah, 2014, Translating the Diabetes Prevention Program into an Online Social Network: Validation against CDC Standards, Diabetes Educ source
The Intervention section describes Prevent as an online adaptation of the National DPP curriculum with small-group support, health coaching, and digital tracking tools. The Results report weight loss and reduced A1C, and the Conclusion and Implications calls it an effective online adaptation for people with prediabetes. The evidence comes from an uncontrolled pilot study, not a randomized trial. (LLM, conf=0.90)
- Partly supportedcites [16] T Moin, 2015, Women veterans' experience with a web-based diabetes prevention program: a qualitative study to inform future practice, J Med Internet Res sourceExperimental — accuracy not yet measured
The Methods describe Prevent as a remotely delivered, Web-based intervention based on the Diabetes Prevention Program, and the Abstract Results report 5.24% mean weight loss among 17 women veterans. However, the Discussion’s Limitations say the weight-loss estimate needs confirmation in a larger study. This exploratory qualitative study does not establish the unqualified clinical efficacy claimed, nor does it describe Prevent as an enhanced version of the original NDPP. (LLM, conf=0.85)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The program exceeds the Centers for Disease Control and Prevention (CDC) Diabetes Prevention Recognition Program standards and eliminates the need for patients to travel to a “brick and mortar” program [14,17].”
§ Clinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular Disease > Methods > Intervention and Study Sample
What the sources say
- Supportedcites [14] W Su, 2016, Return on Investment for Digital Behavioral Counseling in Patients With Prediabetes and Cardiovascular Disease, Prev Chronic Dis source
The Introduction describes the program’s online curriculum, mobile access, and online coach-moderated support groups. The Discussion contrasts online programs with the in-person DPP and says Internet-based delivery helps overcome geographic barriers, supporting the claim that patients need not travel to an in-person program. The Introduction also says programs like this one meet or exceed CDC recognition standards. (LLM, conf=0.88)
- Not checked yetcites [17] Centers for Disease Control and Prevention (CDC) (2015) Centers for Disease Control and Prevention Diabetes Prevention Recognition Program: Standards and Operating Procedures. Available: http://www.cdc.gov/diabetes/prevention/pdf/dprp-standards.pdf.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The program exceeds the Centers for Disease Control and Prevention (CDC) Diabetes Prevention Recognition Program standards and eliminates the need for patients to travel to a “brick and mortar” program [14,17].”
§ Clinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular Disease > Methods > Intervention and Study Sample
What the sources say
- Supportedcites [14] W Su, 2016, Return on Investment for Digital Behavioral Counseling in Patients With Prediabetes and Cardiovascular Disease, Prev Chronic Dis source
The Introduction explicitly says that programs like the digital one modeled in this study “meet or exceed” CDC Diabetes Prevention Recognition Program standards. The claim’s wording is a reasonable paraphrase, although the source says “meet or exceed” rather than that this particular program strictly exceeds them. (LLM, conf=0.93)
- Not checked yetcites [17] Centers for Disease Control and Prevention (CDC) (2015) Centers for Disease Control and Prevention Diabetes Prevention Recognition Program: Standards and Operating Procedures. Available: http://www.cdc.gov/diabetes/prevention/pdf/dprp-standards.pdf.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“and imply that the relative risk reductions seen in NDPP/DPPOS may be higher than what would be expected in a larger population [1,2].”
§ Clinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular Disease > Discussion
What the sources say
- Partly supportedcites [1] 2015, Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study, Lancet Diabetes Endocrinol sourceExperimental — accuracy not yet measured
The Incidence of Diabetes results report that relative reductions fell from 58% and 31% in the initial DPP period to 27% and 18% over 15 years, alongside a decline in placebo-group incidence. The Discussion questions generalizability to other populations but does not estimate control-group incidence or expected relative risk reductions in a larger population. That extrapolation is not supported by this source. (LLM, conf=0.80)
- Partly supportedcites [2] WC Knowler, 2009, 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study, Lancet sourceExperimental — accuracy not yet measured
The Results (page unavailable) report diabetes-incidence reductions relative to placebo and a fall in placebo-group incidence during DPPOS. The paper does not say that these findings imply larger relative risk reductions than would be expected in a broader population, and it does not address NDPP estimates. (LLM, conf=0.78)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
47 more claims · 4 with their cited sources checked
Create a free account to see all 90 claims and to verify the 13 references still open.
- It may state two separate claims as one. 25
- Probably not a substantial claim. 17
- The quote only partly states this claim. 2
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Clinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular Disease > Results > Model Simulation Results
“5.8% (Scenario 2) to 8.2% (Scenario 2) for all participants.”
§ Clinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular Disease > Results > Model Simulation Results
“| Modeled Outcomes | Mortality related expenditure relative reduction, % | 1.5 | 3.3 | 5.8 | 3.7 | 47.5 | 8.2 | 1.8 | 4.5 | 6.1 | 3.1 | 6.1 | 8.4 |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Clinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular Disease > Results > Model Simulation Results
“Reduced medical expenditures are greater for completers versus all participants (Table 3).”
§ Clinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular Disease > Results > Model Simulation Results
“| Modeled Outcomes | Per capita medical expenditures saved, $ b | 1,720 | 3,840 | 11,550 | 1,770 | 4,240 | 14,200 | 1,540 | 3,710 | 12,170 | 1,990 | 4,710 | 15,960 |”
Citations
Cites
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
Cardiovascular disease risk profiles
Anderson, K. M., Odell, P. M., Wilson, P. W. F., & Kannel, W. B. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90861-b · Cited by 2,163
Kannel, W. B., Wolf, P. A., Benjamin, E. J., & Levy, D. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00583-9 · Cited by 2,033
Survival after the onset of congestive heart failure in Framingham Heart Study subjects.
Ho, K. K., Anderson, K. M., Kannel, W. B., Grossman, W., & Levy, D. (1993) · Circulation · doi:10.1161/01.cir.88.1.107 · Cited by 1,869
Influence of Weight Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials
Neter, J. E., Stam, B. E., Kok, F. J., Grobbee, D. E., & Geleijnse, J. M. (2003) · Hypertension · doi:10.1161/01.hyp.0000094221.86888.ae · Cited by 1,391
(2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.334 · Cited by 1,162 · cited 1×
“Sources for these prediction equations include studies such as LookAHEAD [19,25], UK Prospective Diabetes Study (UKPDS) [26– 30], FraminghamHeart Study [24,31,31–35], and other published clinical trials and observational studies [18,19].”
MethodGadde, K. M., Allison, D. B., Ryan, D. H., Peterson, C. A., Troupin, B., Schwiers, M. L., & Day, W. W. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60205-5 · Cited by 1,064
(2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00291-0 · Cited by 1,029
Research works printed but not linked: 1
- KK Ho, 1993, Survival after the onset of congestive heart failure in Framingham Heart Study subjects, Circulation, 88, 107, 10.1161/01.CIR.88.1.107 · DOI · Paper page
Cited by
Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
Evert, A. B., Dennison, M., Gardner, C. D., Garvey, W. T., Lau, K. H. K., MacLeod, J., Mitri, J., Pereira, R. F., Rawlings, K., Robinson, S., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0014 · Cited by 1,496
3. Prevention or Delay of Type 2 Diabetes:Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s003 · Cited by 200
3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s003 · Cited by 204
3. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s003 · Cited by 162
“Cost-effectiveness A cost-effectiveness model suggested that the lifestyle intervention used in the DPP was cost-effective (36,37).”
Background5. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s005 · Cited by 157
“disease, and achieving cost savings (27,28).”
3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s003 · Cited by 144
3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Ebekozien, O., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s003 · Cited by 144
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s003 · Cited by 132
3. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s003 · Cited by 124
“the lifestyle intervention used in the DPP was cost-effective (32,33).”
MethodMason, A. E., Jhaveri, K., Cohn, M., & Brewer, J. A. (2018) · Journal of Behavioral Medicine · doi:10.1007/s10865-017-9884-5 · Cited by 106
“Future work could also add daily self-weighing that sends data to the research team directly (e.g., Chen et al., 2016) to make assessments of each craving and weight more parallel.”
BackgroundResults From a Trial of an Online Diabetes Prevention Program Intervention
Moin, T., Damschroder, L. J., AuYoung, M., Maciejewski, M. L., Havens, K., Ertl, K., Vasti, E., Weinreb, J. E., Steinle, N. I., Billington, C. J., et al. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.06.028 · Cited by 108
Schorr, E. N., Gepner, A. D., Dolansky, M. A., Forman, D. E., Park, L. G., Petersen, K., Still, C. H., Wang, T. Y., & Wenger, N. K. (2021) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/hcq.0000000000000103 · Cited by 107
The Landscape of Diabetic Kidney Disease in the United States
Duru, O. K., Middleton, T. R., Tewari, M. K., & Norris, K. C. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0980-x · Cited by 81
3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., ChallaSivaKanaka, S., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s003 · Cited by 104
Self-citationKyaw, T. L., Ng, N., Theocharaki, M., Wennberg, P., & Sahlèn, K.-G. (2023) · Interactive Journal of Medical Research · doi:10.2196/42396 · Cited by 40
“Some studies (3/20, 15%) used health education at the clinic, counselor-delivered counseling, or pharmacological therapies as comparators [26,29,30], and only 10% (2/20) of studies compared interventions with no intervention [23,35].”
BackgroundMethodInfluentialDall, T. M., Sapra, T., Natale, Z., Livingston, T., & Chen, F. (2024) · Nutrition and Diabetes · doi:10.1038/s41387-024-00352-9 · Cited by 57
Self-citationDigital Health–Supported Lifestyle Change Programs to Prevent Type 2 Diabetes
Kirley, K., & Sachdev, N. (2018) · Diabetes Spectrum · doi:10.2337/ds18-0019 · Cited by 29
“The first study examined a general participant population with prediabetes (38), and the second focused on a Medicare-age population with prediabetes (39).”
BackgroundSapanel, Y., Tadeo, X., Brenna, C. T. A., Remus, A., Koerber, F., Cloutier, L. M., Tremblay, G., Blasiak, A., Hardesty, C. L., Yoong, J., et al. (2023) · Journal of Medical Internet Research · doi:10.2196/47094 · Cited by 33
“[37-39, 44,45,47] involved model-based EE , and 5 ( Of the 18 studies, 14 (78”
InfluentialBen‐Assuli, O. (2022) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2022.104764 · Cited by 31
Willems, R. P., Annemans, L., Siopis, G., Moschonis, G., Vedanthan, R., Jung, J., Kwaśnicka, D., Oldenburg, B. F., D’Antonio, C., Girolami, S., et al. (2023) · npj Digital Medicine · doi:10.1038/s41746-023-00876-x · Cited by 34
Building Toward a Population-Based Approach to Diabetes Screening and Prevention for US Adults
Bowen, M. E., Schmittdiel, J. A., Kullgren, J. T., Ackermann, R. T., & O’Brien, M. J. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1090-5 · Cited by 23
Dessy, A. M., Zhao, A. J., Kyaw, K. T., Vieira, D. L., & Salinas, J. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220005 · Cited by 24
Komkova, A., Brandt, C. J., Pedersen, D. H., Emneus, M., & Sortsø, C. (2018) · JMIR Diabetes · doi:10.2196/12140 · Cited by 28
“In addition, current research on the CGM sensor has mostly focused on European countries and the United States [7-12].”
BackgroundInfluentialImpact of a Digitally Enhanced Diabetes Self-Management Program on Glycemia and Medical Costs
Chen, F., Jasik, C. B., Dall, T. M., & Siego, C. V. (2022) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106221100779 · Cited by 20
Self-citationNavigating Privacy and Security in Telemedicine for Primary Care
Andreadis, K., Muellers, K. A., Lin, J. J., Mkuu, R., Horowitz, C. R., Kaushal, R., & Ancker, J. S. (2024) · The American Journal of Managed Care · doi:10.37765/ajmc.2024.89553 · Cited by 25
Horstman, C. M., Ryan, D. H., Aronne, L. J., Apovian, C. M., Foreyt, J. P., Tuttle, H. M., & Williamson, D. A. (2021) · Obesity · doi:10.1002/oby.23117 · Cited by 16
Ten-year Medicare budget impact of increased coverage for anti-obesity intervention
Chen, F., Su, W., Ramasamy, A., Zvenyach, T., Kahan, S. I., Kyle, T. K., & Ganguly, R. (2019) · Journal of Medical Economics · doi:10.1080/13696998.2019.1652185 · Cited by 15
Self-citationPhysician Preferences for an Electronic Lung Cancer Screening Decision Aid
Morgan, O., Schnur, J. B., Diefenbach, M. A., & Kale, M. (2024) · The American Journal of Managed Care · doi:10.37765/ajmc.2024.89551 · Cited by 16
Heo, M., Meißner, P., Litwin, A. H., Arnsten, J. H., McKee, M. D., Karasz, A., McKinley, P. S., Rehm, C. D., Chambers, E. C., Yeh, M.-C., et al. (2017) · Statistical Methods in Medical Research · doi:10.1177/0962280217734584 · Cited by 16
A Digital Coaching Intervention for Cancer Survivors With Job Loss: Retrospective Study
Lo, J., Ballurkar, K., Fox, S., Tynan, K., Luu, N., Boyer, M. J., & Murali-Ganesh, R. (2021) · JMIR Cancer · doi:10.2196/31966 · Cited by 12
Hafez, D., Kullgren, J. T., Liestenfeltz, B., Richardson, C. R., & Heisler, M. (2018) · Pilot and Feasibility Studies · doi:10.1186/s40814-018-0246-z · Cited by 10
“Although web-based DPPs [20, 21] and growing insurance coverage for program participation [22–24] can reduce logistical barriers, these strategies alone have been inadequate to increase rates of DPP engagement.”
BackgroundEquity and AI Governance at Academic Medical Centers
(2024) · The American Journal of Managed Care · doi:10.37765/ajmc.2024.89555 · Cited by 12
Impact on dietary intake of a self-directed, gender-tailored diabetes prevention program in men
Rollo, M. E., Aguiar, E. J., Pursey, K., Morgan, P. J., Plotnikoff, R. C., Young, M. D., Collins, C. E., & Callister, R. (2017) · World Journal of Diabetes · doi:10.4239/wjd.v8.i8.414 · Cited by 8
Collecting health-related research data using consumer-based wireless smart scales
Johannessen, E., Johansson, J., Hartvigsen, G., Horsch, A., Årsand, E., & Henriksen, A. (2023) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2023.105043 · Cited by 9
Modeling the Economic Value of Cardiometabolic Virtual-First Care Programs
Noble, M. L., Chen, F., Linke, S., Dall, T. M., & Napoleone, J. (2024) · The American Journal of Managed Care · doi:10.37765/ajmc.2024.89549 · Cited by 7
Wang, Y., Zhang, P., Xing, Y., Shi, H., Cui, Y.-P., Wei, Y., Zhang, K., Wu, X., Ji, H. Q., Xu, X., et al. (2024) · Journal of Medical Internet Research · doi:10.2196/57814 · Cited by 7
“However, in numerous studies, telemedicine was mostly used as a supplementary tool for conventional care, serving as a platform for patient-physician interactions and a channel for patient education [9-12].”
Barthold, D., Chiguluri, V., Gumpina, R., Castro, C. M., Pieratt, J., Cordier, T., Matanich, R., Rogstad, T. L., & PREWITT, T. G. (2020) · Population Health Management · doi:10.1089/pop.2019.0184 · Cited by 4
Self-citationFitzpatrick, S. L., Mayhew, M., Rawlings, A. M., Smith, N., Nyongesa, D. B., Vollmer, W. M., Stevens, V. J., Grall, S. K., & Fortmann, S. P. (2022) · Clinical Diabetes · doi:10.2337/cd21-0114 · Cited by 5
Fitzpatrick, S. L., Mayhew, M., Catlin, C., Firemark, A. J., Gruß, I., Nyongesa, D. B., O'Keeffe-Rosetti, M. C., Rawlings, A. M., Smith, D. H., Smith, N. X., et al. (2022) · The Permanente Journal · doi:10.7812/tpp/21.056 · Cited by 6
Mayhew, M., Smith, N. X., Fortmann, S. P., & Fitzpatrick, S. L. (2022) · Obesity Science & Practice · doi:10.1002/osp4.644 · Cited by 5
Su, W., Chen, F., Dall, T. M., Zvenyach, T., Kyle, T. K., & Perreault, L. (2018) · Journal of Medical Economics · doi:10.1080/13696998.2018.1496922 · Cited by 5
Self-citationPractical Tips for Implementing the Diabetes Prevention Program in Clinical Practice
Jasik, C. B., Joy, E. A., Brunisholz, K. D., & Kirley, K. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1034-0 · Cited by 6
Physicians in ACOs Report Greater Documentation Burden
Apathy, N. C., Patel, V., Rolle, T. L., & Holmgren, A. J. (2024) · The American Journal of Managed Care · doi:10.37765/ajmc.2024.89552 · Cited by 4
Pros and Cons of Telemedicine: Implications in Cardiology and Cardiovascular Medicine
Gerges, S., & Hallit, S. R. (2022) · Future Cardiology · doi:10.2217/fca-2022-0065 · Cited by 4
Gannamani, R., Forte, J. C., Folkertsma, P., Hermans, S., Kumaraswamy, S., van Dam, S., Chavannes, N. H., van Os, H. J. A., Pijl, H., & Wolffenbuttel, B. H. R. (2023) · JMIR Formative Research · doi:10.2196/38891 · Cited by 3
“A study on a subset of this cohort was published previously in JMIR Cardio [31].”
BackgroundInfluentialBonner, T. J., Ayyanar, P., Milam, A. J., & Blocker, R. C. (2024) · The American Journal of Managed Care · doi:10.37765/ajmc.2024.89547 · Cited by 3
Zink, A., Boone, C., Maddox, K. E. J., Chernew, M. E., & Neprash, H. T. (2024) · The American Journal of Managed Care · doi:10.37765/ajmc.2024.89556 · Cited by 5
Implementing Team-Based Telemedicine Workflows in Safety-Net Primary Care
Kong, M., Willard-Grace, R., Khoong, E., Sharma, A., Mukerjee, M., Su, G., & Tuot, D. (2024) · The American Journal of Managed Care · doi:10.37765/ajmc.2024.89550 · Cited by 9
Tabor, V., Tabor, M. H., Keestra, S., Parrot, J.-E., & Alvergne, A. (2021) · Women s Health Reports · doi:10.1089/whr.2021.0010 · Cited by 8
Chen, F., Dall, T. M., Ferguson, C. C., Sapra, T., Hafida, S., Livingston, T., ElSayed, N. A., Moody, A., & Bannuru, R. R. (2026) · Diabetes Obesity and Cardiometabolic CARE · doi:10.2337/doci25-0004 · Cited by 2
Self-citationSaudi Consensus on Medical Nutrition Therapy for Type 2 Diabetes Mellitus
Alsheikh, A., Abulmeaty, M. M. A., Al-Othman, A. M., Bawazeer, N. M., Hamdy, O., Alsifri, S. N., & Issak, E. R. (2023) · Saudi Journal of Medicine · doi:10.36348/sjm.2023.v08i12.001 · Cited by 2
Rafferty, A. (2020) · Arizona State University Library Digital Repository (Arizona State University)
Bakhtiari, A., Jahanmehr, N., & Izadi, R. (2021)
Medicine as a Job and Not as a Career—Recruiting and Retaining an Evolving Physician Workforce
Poole, K., & Seidel, Z. (2022) · Physician leadership journal · doi:10.55834/plj.3216612343 · Cited by 1
Interventional Analytics in Skilled Nursing Facilities Associated With Reduced Readmissions
Kaknes, D., Barbour, T. B., Ji, W., Stein, S. M., Naylor, M. D., & Hanlon, A. L. (2024) · The American Journal of Managed Care · doi:10.37765/ajmc.2024.89557 · Cited by 2
Shared Decision-Making for Lung Cancer Screening: More Straw for the Camel’s Back
Green, J. (2024) · The American Journal of Managed Care · doi:10.37765/ajmc.2024.89548
A Scoping Review of Microsimulation Models on Obesity-Related Policy Evaluation
Cao, Z., Fang, Y., Wang, C., & An, R. (2025) · Nutrients · doi:10.3390/nu18010073
Mercadal-Orfila, G., Hazas, J. I. S. L. D. L., Mijares, T., Vidal, L., Curran, A., & Herrera-Pérez, S. (2026) · Journal of Medical Internet Research · doi:10.2196/87592 · Cited by 1
Motivating Patients to Engage in Evidence-Based Strategies to Prevent Diabetes: An RCT
Kullgren, J. T., STOLL, S. C., Carter, E. W., Vadari, H. S., Resnicow, K., Herman, W. H., Kim, H. M., McEwen, L. N., Volpp, K. G. M., & Heisler, M. (2026) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2026.108407
Liu, W., Zhao, J., Zhang, D., Dang, C., Lu, Y., & Du, X. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1955223
Metadata
- Authors
- Chen, F., Su, W., Becker, S. H., Payne, M., Castro Sweet, C. M., Peters, A. L., & Dall, T. M.
- Affiliations
- University of Southern California (US)
- Corresponding author
- Chen, Fang
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-10-05
- Volume
- 11
- Issue
- 10
- Pages
- e0163627
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5051965
- OpenAlex
- W2523103777
- Semantic Scholar
- 8d9fbb1c0713d3b27f24114e0a2bb1a8d04e7502
- Cited by
- 60
- References
- 34
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 13 · 2023: 7 · 2022: 9 · 2021: 6 · 2020: 3 · 2019: 3 · 2018: 9 · 2017: 4
- FWCI
- 10.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Omada Health, Inc.
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Keywords
- digital health interventions, National Diabetes Prevention Program, type 2 diabetes prevention, cardiovascular disease prevention, Medicare beneficiaries, older adults, weight loss, obesity, prediabetes, stroke, medical cost savings, weight regain, USPSTF recommendations
- MeSH terms
- Aged, Aged, 80 and over, Cardiovascular Diseases, Cost-Benefit Analysis, Counseling, Diabetes Mellitus, Type 2, Female, Medicare, Humans, Hypoglycemic Agents, Male, Markov Chains, Models, Theoretical, Risk Factors, United States, Remote Consultation, Weight Reduction Programs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.